Digital Power Corporation (DPW): Crypto-Thriller Turns Into Stockholder-Chiller
by Sonya Colberg, Senior Editor, 12/12/2017 11:42:41 AM
TheStreetSweeper issues an alert for Digital Power Corporation (DPW) investors!
The Fremont, California company has lost money six out of the last nine years since hitting the stock exchange. Revenue captured back in the day - when its electronic power products sold fairly well to European businesses and the military – has dropped by 36%. And the early years’ razor-thin profits have disintegrated into $1 million losses.
So Digital Power has jumped onto the investor-frenzied cryptocurrency rollercoaster. But the market is missing the risks that lurk around every bend, including:
*SELLING. While the stock price was very high after the closing bell Monday, Digital filed notice to sell 640,000 shares … representing a major watering down of investors’ stock.
*CRUNCH: Cash is very low, while working capital is negative at $-4 million. Virtually impossible for the company to manage $9.8 million in short-term liabilities.
*ODD: Curious perks for the CEO’s daughter.
*SELLERS: Majority stockholders have lined up to sell cheap Digital Power stock at crypto-fueled prices. More dilutive actions loom dead ahead.
*DISINTERESTED: Big, reputable institutional firms are yawning at Digital Power. When the investment banks, big retirement funds and other significant institutions hold less than 3% of the stock, it doesn't exactly inspire confidence.
*BAN: A major gaming company’s recent ban on bitcoin transactions foretells trouble.
*CHOICES: If you want bitcoin-related, this stock isn't it. Digital's plan is just an idea right now. Investors may choose from nearly 1,000 bitcoin-related companies listed in our link:
(Source: Coinmarketcap, TheStreetSweeper)
Dicerna Pharmaceuticals (DRNA): Taking Investors Down A Hole?
by Sonya Colberg, Senior Editor, 11/20/2017 8:56:58 AM
Dicerna Pharmaceuticals (DRNA), an experimental RNA-based technology company, is a sudden highflyer that we believe is positioned to plunge. Issues include:
*Company leadership is tied to another RNA-based company, Genta, a spectacular biotech bomb that burned up $1.2 billion in investors’ money before it fizzled into oblivion.
*The recent development deal with Boehringer isn’t all it’s cracked up to be. Deals like this come and go frequently. Indeed, Dicerna itself lost a similar $25 million deal last year.
*Dicerna has already tried – and failed – to advance a product beyond Phase 1 human trials. That failure cost the company over $41 million.
*Dicerna has switched focus to GalXC and merely hopes to submit application to the FDA for US clinical trials next year. If approved, Dicerna would take investors down a costly, 6-year to 11-year road of human trials.
*The stock is overvalued at this point and extremely risky.
JAMN Finally Spills the Beans -- And It's an Ugly Mess
by Janice Shell, 6/2/2011 10:32:51 AM
To be sure, the 10-K offered investors little reason to sing. For starters, the filing reveals, this once-hot “coffee company” sells no coffee of its own at all. JAMN relies on a supplier based in frigid Canada – far away from the tropical Jamaican home of its co-founder Rohan Marley – to provide the company with an actual product to sell to its customers instead.
Back in April of 2010, JAMN inked a “supply and toll agreement” with Canterbury Coffee of British Columbia that gave it access to some brew. According to that agreement, JAMN relies on Canterbury to fulfill every role – save a minor one – normally satisfied by a firm that classifies itself as a coffee company. Canterbury purchases the coffee beans. It roasts them. And it then packages them in bags supplied by JAMN – the company’s only real product – for sale to the public.
JAMN signed this deal more than a year ago, right before Shane Whittle – a notorious Vancouver stock promoter – officially resigned as CEO of the company. But the company never mentioned that agreement, seemingly material enough to warrant at least a quiet 8-K report, in a single regulatory filing until now.
Jammin Java (JAMN): Hot Stock ... Bitter Aftertaste?
by Janice Shell, 6/2/2011 10:30:25 AM
It’s time to wake up and smell the coffee! That’s exactly what Jammin Java (OTC: JAMN.OB), a heavily promotedcoffee company, and – for very different reasons – TheStreetSweeper would like investors to do.
Since the beginning of the year, JAMN has miraculously risen from the ashes of the “Grey Market” graveyard to become one of the liveliest – and richest – stocks in the entire microcap arena. JAMN has seen its stock shoot straight toward heaven, soaring from 55 cents to peak above $6 a share on massive daily volume, with its market value nowtopping $355 million despite the company’s limited resources and operating history. (As covered in more detail below, two of the Internet tout sheets pushing JAMN the hardest effectively vanished -- disabled by their Internet servers -- on the day the stock’s trading volume exploded past 20 million shares.)
CCME: Few Signs of Life at 'Healthy' Chinese Firm
by Roddy Boyd, 3/23/2011 9:30:34 AM
Also, and this cannot be understated, hanging out on a sidewalk in Fujian–the sidewalks double as parking spots when the streets, which appeared to have been designed in the Han Dynasty, fill up–was not a viable option. There was also the matter of the world-class headache the Financial Investigator was developing from Fuzhou’s diabolical smell, an epic conflation of poor sewage treatment, air pollution and the smell of cabbage that made getting the hell off Dongjie street a matter of vital importance.
The Financial Investigator and his traveling companion for the trip, an American investor with extensive experience in China, decided to head upstairs despite our interview with the CFO having been cancelled at the last minute (with no explanation given.) We thought a quick tour of the offices and meeting a few other executives might open our eyes to a few things.
Though the language barrier was a little steep with the young receptionist–when we asked for writing paper, she provided Kleenex–we were in short order shown to their conference room and told to wait. It did not escape notice that pride of place in the conference room belonged to a framed certificate of participation from the Fall 2010 Rodman & Renshaw conference, the World Cup for reverse merger companies and the pumpers and touts who peddle them.
Eventually chief operating officer James Yu came down and after spending 30 minutes trying to understand who we were, concluded that giving us a tour wouldn’t hurt. Soon enough, his colleague, Vinne Ye–the chairman’s assistant–came out and took us around.
It was most eye-opening.more...
Signup For Alerts
When new stories are published
CNBC on TheStreetSweeper's coverage of Miller Energy Resources: (MILL):
"Melissa Davis at TheStreetSweeper … wrote a piece on this thing that obviously scared investors a little bit … It was an excellent reporting job (and) has moved the stock dramatically."
Watch the Video
Read the MILL Story
Investors must be properly armed in order to protect themselves against the dangers of Wall Street. To help out, The Street Sweeper has mined the Internet for the most powerful weapons available to investors researching publicly traded companies. In our “Loaded Weapons” section, you’ll find direct links to corporate documents filed with the SEC, conference call transcripts published by Seeking Alpha, insider stock sales tracked by Insider-Monitor.com and popular investment tools offered by Yahoo! Finance. You can also identify the promoters behind current penny stock campaigns – and the compensation they are receiving – by connecting to StockPromoters.com. You can link to other websites that are conducting topnotch stock investigations as well. Click here now.